Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1075 | 944 | 1125 | 1158 | 1447 | 2489 |
Fund Return | 7.53% | -5.62% | 12.5% | 5% | 7.67% | 9.55% |
Place in category | 353 | 659 | 410 | 133 | 126 | 82 |
% in Category | 36 | 69 | 44 | 22 | 25 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.53B | 14.61 | 10.47 | 14.99 | ||
Legal General US Index Trust C Dist | 847.63M | 14.53 | 10.45 | 14.98 | ||
Legal General US Index Trust F Acc | 554.02K | 27.45 | 11.76 | 14.94 | ||
Legal General US Index Trust F Dist | 23.41K | 27.39 | 11.74 | 14.94 | ||
Legal General US Index Trust I Acc | 1.67B | 27.75 | 12.04 | 15.23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.79B | 11.21 | 7.04 | 12.01 | ||
Wellington Global Health Care EquiG | 2B | 6.70 | 4.03 | 11.14 | ||
Global Health Care Fund W Acc GBP | 105.48M | 8.57 | 4.09 | 10.65 | ||
Adamant Medtech I GBP | 1.53B | 14.50 | 4.03 | 12.68 | ||
Pharmaceuticals Index Trust I Acc | 504.31M | 7.70 | 5.13 | 9.70 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 793.68 | +3.38% | |
UnitedHealth | US91324P1021 | 6.67 | 506.84 | +1.34% | |
J&J | US4781601046 | 4.97 | 144.70 | +0.16% | |
AbbVie | US00287Y1091 | 4.65 | 177.27 | +0.96% | |
Novo Nordisk B | DK0062498333 | 4.42 | 622.6 | +5.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review